Atrys Health Sa Stock Earnings Per Share
| A2T Stock | EUR 3.00 0.01 0.33% |
ATRYS HEALTH SA fundamentals help investors to digest information that contributes to ATRYS HEALTH's financial success or failures. It also enables traders to predict the movement of ATRYS Stock. The fundamental analysis module provides a way to measure ATRYS HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ATRYS HEALTH stock.
ATRYS |
ATRYS HEALTH SA Company Earnings Per Share Analysis
ATRYS HEALTH's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current ATRYS HEALTH Earnings Per Share | (0.05) X |
Most of ATRYS HEALTH's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATRYS HEALTH SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, ATRYS HEALTH SA has an Earnings Per Share of -0.05 times. This is 100.6% lower than that of the Healthcare sector and 98.96% lower than that of the Biotechnology industry. The earnings per share for all Germany stocks is 101.6% higher than that of the company.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
ATRYS Fundamentals
| EBITDA | 6.68 M | |||
| Net Income | (2.02 M) | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 71.4 M | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 1.53 X | |||
| Cash Flow From Operations | (1.4 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 2.4 K | |||
| Beta | 0.15 | |||
| Market Capitalization | 330.53 M | |||
| Z Score | 2.4 |
About ATRYS HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ATRYS HEALTH SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATRYS HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATRYS HEALTH SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.